Ablation of Transcription Factor IRF4 Promotes Transplant Acceptance by Driving Allogenic CD4+ T Cell Dysfunction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ablation of Transcription Factor IRF4 Promotes Transplant Acceptance by Driving Allogenic CD4+ T Cell Dysfunction

Published:2017-12 Issue:6 Volume:47 Page:1114-1128.e6
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Wu Jie,Zhang Hedong,Shi Xiaomin,Xiao Xiang,Fan Yihui,Minze Laurie J.,Wang Jin,Ghobrial Rafik M.,Xia Jiahong,Sciammas Roger,Li Xian C.,Chen Wenhao

Funder

American Heart Association

Houston Methodist Research Institute

US National Institutes of Health

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference50 articles.

1. Checkpoint inhibitors in kidney transplant recipients and the potential risk of rejection;Alhamad;Am. J. Transplant.,2016

2. Genetic and epigenetic regulation of PD-1 expression;Bally;J. Immunol.,2016

3. Coinhibitory pathways in immunotherapy for cancer;Baumeister;Annu. Rev. Immunol.,2016

4. Transcription factor IRF4 determines germinal center formation through follicular T-helper cell differentiation;Bollig;Proc. Natl. Acad. Sci. USA,2012

5. Cellular requirements for renal allograft rejection in the athymic nude rat;Bolton;J. Exp. Med.,1989

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IRF4 impedes human CD8 T cell function and promotes cell proliferation and PD-1 expression;Cell Reports;2024-07

2. Inhibition of interferon regulatory factor 4 orchestrates T cell dysfunction, extending mouse cardiac allograft survival;Chinese Medical Journal;2024-05-29

3. Targeted depletion of PD-1–expressing cells induces immune tolerance through peripheral clonal deletion;Science Immunology;2024-04-26

4. MEK1/2-PKM2 Pathway Modulates the Immunometabolic Reprogramming of Proinflammatory Allograft-Infiltrating Macrophages During Heart Transplant Rejection;Transplantation;2024-01-19

5. CD4+ T cell immunity is dependent on an intrinsic stem-like program;Nature Immunology;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3